Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

ILLUMINATE sheds light on mechanisms of torcetrapib-induced harm

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJP, Komajda M, Lopez-Sendon J, Mosca L, Tardif J-C, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B, ILLUMINATE Investigators.Effects of torcetrapib in patients at high risk for coronary events. New England Journal of Medicine 357: 2109-2122, No. 21, 22 Nov 2007

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    ILLUMINATE sheds light on mechanisms of torcetrapib-induced harm. React. Wkly. 1178, 3–4 (2007). https://doi.org/10.2165/00128415-200711780-00005

    Download citation

    Keywords

    • Atorvastatin
    • Cholesteryl Ester Transfer Protein
    • Torcetrapib
    • Data Safety Monitoring Board
    • Cholesteryl Ester Transfer Protein Inhibition